Shopping Cart 0
Cart Subtotal
AED 0

Genomic Health Inc (GHDX) - Financial and Strategic SWOT Analysis Review

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
AED 459

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
AED 918

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
AED 1376

Details

Genomic Health Inc (GHDX)-Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description-A detailed description of the company's operations and business divisions.

- Corporate strategy-Analyst's summarization of the company's business strategy.

- SWOT Analysis-A detailed analysis of the company's strengths, weakness, opportunities and threats.

- Company history-Progression of key events associated with the company.

- Major products and services-A list of major products, services and brands of the company.

- Key competitors-A list of key competitors to the company.

- Key employees-A list of the key executives of the company.

- Executive biographies-A brief summary of the executives' employment history.

- Key operational heads-A list of personnel heading key departments/functions.

- Important locations and subsidiaries-A list and contact details of key locations and subsidiaries of the company.

- Detailed financial ratios for the past five years-The latest financial ratios derived from the annual financial statements published by the company with 5 years history.

- Interim ratios for the last five interim periods-The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Genomic Health Inc (Genomic Health) is a provider of genomic-based diagnostic tests and clinical laboratory services for the diagnosis of cancer. The company's commercial product portfolio comprises Onco type DX breast cancer test, Onco type DX colon cancer test, Onco type DX prostate cancer test and Oncotype SEQ Liquid Select liquid biopsy mutation panel. Genomic Health develops these products using its Oncotype IQ Genomic Intelligence Platform, a technology which uses RT-PCR approach to improve cancer treatment decisions. The company has operations in North America, Europe and Asia through direct offices, subsidiaries and distributors. Genomic Health is headquartered in Redwood City, California, the US.

Genomic Health Inc Key Recent Developments

May 07,2019: Genomic Health announces first quarter 2019 financial results

Feb 20,2019: Genomic Health reports record 2018 fourth quarter and year-end financial results and provides 2019 financial guidance

Sep 12,2018: Epic Sciences Announces Completion of USD 52 Million Series E Financing

Aug 02,2018: Genomic Health reports second quarter 2018 financial results

May 02,2018: Genomic Health Reports First Quarter 2018 Financial Results

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

- The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.

- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents

List of Tables

List of Figures

Section 1-About the Company

Genomic Health Inc-Key Facts

Genomic Health Inc-Key Employees

Genomic Health Inc-Key Employee Biographies

Genomic Health Inc-Major Products and Services

Genomic Health Inc-History

Genomic Health Inc-Company Statement

Genomic Health Inc-Locations And Subsidiaries

Head Office

Other Locations & Subsidiaries

Section 2-Company Analysis

Company Overview

Genomic Health Inc-Business Description

Geographical Segment: Outside of the US

Performance

Geographical Segment: The US

Performance

R&D Overview

Genomic Health Inc-Corporate Strategy

Genomic Health Inc-SWOT Analysis

SWOT Analysis-Overview

Genomic Health Inc-Strengths

Genomic Health Inc-Weaknesses

Genomic Health Inc-Opportunities

Genomic Health Inc-Threats

Genomic Health Inc-Key Competitors

Section 3-Company Financial Ratios

Financial Ratios-Capital Market Ratios

Financial Ratios-Annual Ratios

Performance Chart

Financial Performance

Financial Ratios-Interim Ratios

Financial Ratios-Ratio Charts

Section 4-Company's Lifesciences Financial Deals and Alliances

Genomic Health Inc, Medical Equipment, Deals By Year, 2013 to YTD 2019

Genomic Health Inc, Medical Equipment, Deals By Type, 2013 to YTD 2019

Genomic Health Inc, Recent Deals Summary

Section 5-Company's Recent Developments

May 07, 2019: Genomic Health announces first quarter 2019 financial results

Feb 20, 2019: Genomic Health reports record 2018 fourth quarter and year-end financial results and provides 2019 financial guidance

Sep 12, 2018: Epic Sciences Announces Completion of USD 52 Million Series E Financing

Aug 02, 2018: Genomic Health reports second quarter 2018 financial results

May 02, 2018: Genomic Health Reports First Quarter 2018 Financial Results

Mar 08, 2018: Genomic Health Announces 2017 Fourth Quarter and Year-end Financial Results, Provides 2018 Financial Outlook

Section 6-Appendix

Methodology

Ratio Definitions

About GlobalData

Contact Us

Disclaimer


List Of Figure

List of Figures

Genomic Health Inc, Performance Chart (2014-2018)

Genomic Health Inc, Ratio Charts

Genomic Health Inc, Medical Equipment, Deals By Year, 2013 to YTD 2019

Genomic Health Inc, Medical Equipment, Deals by Type, 2013 to YTD 2019


List Of Table

List of Tables

Genomic Health Inc, Key Facts

Genomic Health Inc, Key Employees

Genomic Health Inc, Key Employee Biographies

Genomic Health Inc, Major Products and Services

Genomic Health Inc, History

Genomic Health Inc, Other Locations

Genomic Health Inc, Subsidiaries

Genomic Health Inc, Key Competitors

Genomic Health Inc, Ratios based on current share price

Genomic Health Inc, Annual Ratios

Genomic Health Inc, Annual Ratios (Cont...1)

Genomic Health Inc, Interim Ratios

Genomic Health Inc, Medical Equipment, Deals By Year, 2013 to YTD 2019

Genomic Health Inc, Medical Equipment, Deals By Type, 2013 to YTD 2019

Genomic Health Inc, Recent Deals Summary

Currency Codes

Capital Market Ratios

Equity Ratios

Profitability Ratios

Cost Ratios

Liquidity Ratios

Leverage Ratios

Efficiency Ratios

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products and Companies

Products

Genomic Health Inc, SWOT analysis, SWOT, Strengths, Weaknesses, Opportunities, Threats, Corporate Strategy, Key Ratios, Share Data, Performance, Financial Performance, Overview, Business Description, Major Product, Brands, History,Key Employees, Key Operational Heads, Strategy, Key Competitors, Company Statement, Capital Market Ratios, Financial Ratios, Annual Ratios, Interim Ratios, Ratio Charts


Companies

Siemens AG

Roche Diagnostics International Ltd

Qiagen NV

Personal Genome Diagnostics Inc

OPKO Health Inc

NeoGenomics Inc

Natera Inc

NanoString Technologies Inc

Myriad Genetics Inc

Metamark Genetics Inc

MDxHealth SA

Hologic Inc

Guardant Health Inc

Grail Inc

GenomeDx Biosciences Inc

Exact Sciences Corp

Danaher Corp

bioTheranostics Inc

Bio Techne Corp

Agendia Inc

Company Profile

Company Profile Title

Genomic Health Inc (GHDX)-Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description-A detailed description of the company's operations and business divisions.

- Corporate strategy-Analyst's summarization of the company's business strategy.

- SWOT Analysis-A detailed analysis of the company's strengths, weakness, opportunities and threats.

- Company history-Progression of key events associated with the company.

- Major products and services-A list of major products, services and brands of the company.

- Key competitors-A list of key competitors to the company.

- Key employees-A list of the key executives of the company.

- Executive biographies-A brief summary of the executives' employment history.

- Key operational heads-A list of personnel heading key departments/functions.

- Important locations and subsidiaries-A list and contact details of key locations and subsidiaries of the company.

- Detailed financial ratios for the past five years-The latest financial ratios derived from the annual financial statements published by the company with 5 years history.

- Interim ratios for the last five interim periods-The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Genomic Health Inc (Genomic Health) is a provider of genomic-based diagnostic tests and clinical laboratory services for the diagnosis of cancer. The company's commercial product portfolio comprises Onco type DX breast cancer test, Onco type DX colon cancer test, Onco type DX prostate cancer test and Oncotype SEQ Liquid Select liquid biopsy mutation panel. Genomic Health develops these products using its Oncotype IQ Genomic Intelligence Platform, a technology which uses RT-PCR approach to improve cancer treatment decisions. The company has operations in North America, Europe and Asia through direct offices, subsidiaries and distributors. Genomic Health is headquartered in Redwood City, California, the US.

Genomic Health Inc Key Recent Developments

May 07,2019: Genomic Health announces first quarter 2019 financial results

Feb 20,2019: Genomic Health reports record 2018 fourth quarter and year-end financial results and provides 2019 financial guidance

Sep 12,2018: Epic Sciences Announces Completion of USD 52 Million Series E Financing

Aug 02,2018: Genomic Health reports second quarter 2018 financial results

May 02,2018: Genomic Health Reports First Quarter 2018 Financial Results

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

- The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.

- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

READ MORE

Scope

Table of Contents

Table of Contents

List of Tables

List of Figures

Section 1-About the Company

Genomic Health Inc-Key Facts

Genomic Health Inc-Key Employees

Genomic Health Inc-Key Employee Biographies

Genomic Health Inc-Major Products and Services

Genomic Health Inc-History

Genomic Health Inc-Company Statement

Genomic Health Inc-Locations And Subsidiaries

Head Office

Other Locations & Subsidiaries

Section 2-Company Analysis

Company Overview

Genomic Health Inc-Business Description

Geographical Segment: Outside of the US

Performance

Geographical Segment: The US

Performance

R&D Overview

Genomic Health Inc-Corporate Strategy

Genomic Health Inc-SWOT Analysis

SWOT Analysis-Overview

Genomic Health Inc-Strengths

Genomic Health Inc-Weaknesses

Genomic Health Inc-Opportunities

Genomic Health Inc-Threats

Genomic Health Inc-Key Competitors

Section 3-Company Financial Ratios

Financial Ratios-Capital Market Ratios

Financial Ratios-Annual Ratios

Performance Chart

Financial Performance

Financial Ratios-Interim Ratios

Financial Ratios-Ratio Charts

Section 4-Company's Lifesciences Financial Deals and Alliances

Genomic Health Inc, Medical Equipment, Deals By Year, 2013 to YTD 2019

Genomic Health Inc, Medical Equipment, Deals By Type, 2013 to YTD 2019

Genomic Health Inc, Recent Deals Summary

Section 5-Company's Recent Developments

May 07, 2019: Genomic Health announces first quarter 2019 financial results

Feb 20, 2019: Genomic Health reports record 2018 fourth quarter and year-end financial results and provides 2019 financial guidance

Sep 12, 2018: Epic Sciences Announces Completion of USD 52 Million Series E Financing

Aug 02, 2018: Genomic Health reports second quarter 2018 financial results

May 02, 2018: Genomic Health Reports First Quarter 2018 Financial Results

Mar 08, 2018: Genomic Health Announces 2017 Fourth Quarter and Year-end Financial Results, Provides 2018 Financial Outlook

Section 6-Appendix

Methodology

Ratio Definitions

About GlobalData

Contact Us

Disclaimer


List Of Figure

List of Figures

Genomic Health Inc, Performance Chart (2014-2018)

Genomic Health Inc, Ratio Charts

Genomic Health Inc, Medical Equipment, Deals By Year, 2013 to YTD 2019

Genomic Health Inc, Medical Equipment, Deals by Type, 2013 to YTD 2019


List Of Table

List of Tables

Genomic Health Inc, Key Facts

Genomic Health Inc, Key Employees

Genomic Health Inc, Key Employee Biographies

Genomic Health Inc, Major Products and Services

Genomic Health Inc, History

Genomic Health Inc, Other Locations

Genomic Health Inc, Subsidiaries

Genomic Health Inc, Key Competitors

Genomic Health Inc, Ratios based on current share price

Genomic Health Inc, Annual Ratios

Genomic Health Inc, Annual Ratios (Cont...1)

Genomic Health Inc, Interim Ratios

Genomic Health Inc, Medical Equipment, Deals By Year, 2013 to YTD 2019

Genomic Health Inc, Medical Equipment, Deals By Type, 2013 to YTD 2019

Genomic Health Inc, Recent Deals Summary

Currency Codes

Capital Market Ratios

Equity Ratios

Profitability Ratios

Cost Ratios

Liquidity Ratios

Leverage Ratios

Efficiency Ratios

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products

Genomic Health Inc, SWOT analysis, SWOT, Strengths, Weaknesses, Opportunities, Threats, Corporate Strategy, Key Ratios, Share Data, Performance, Financial Performance, Overview, Business Description, Major Product, Brands, History,Key Employees, Key Operational Heads, Strategy, Key Competitors, Company Statement, Capital Market Ratios, Financial Ratios, Annual Ratios, Interim Ratios, Ratio Charts


Companies

Siemens AG

Roche Diagnostics International Ltd

Qiagen NV

Personal Genome Diagnostics Inc

OPKO Health Inc

NeoGenomics Inc

Natera Inc

NanoString Technologies Inc

Myriad Genetics Inc

Metamark Genetics Inc

MDxHealth SA

Hologic Inc

Guardant Health Inc

Grail Inc

GenomeDx Biosciences Inc

Exact Sciences Corp

Danaher Corp

bioTheranostics Inc

Bio Techne Corp

Agendia Inc